Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort

Clinical trial NCT06649721 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06649721
Sponsor: Huashan Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Drug-resistant Tuberculosis Pulmonary Tuberculosis Rifampin-resistant Tuberculosis

Start date: 2024-11-27
Primary completion: 2027-02-28
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.